AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01388556 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tango dancing
Description: Twice weekly tango dance classes
Study NCT00362973 — intervention group
Intervention type: PROCEDURE
Intervention: positron emission tomography
Study NCT00362973 — intervention group
Intervention type: PROCEDURE
Intervention: radionuclide imaging
Study NCT00362973 — intervention group
Intervention type: RADIATION
Intervention: fludeoxyglucose F 18
Study NCT02816567 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: propofol
Study NCT02816567 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: propofol
Study NCT02816567 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NMBA - cisatracurium
Study NCT00535951 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBH589
Study NCT05369247 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity Interval Training
Description: HIIT protocol consisted of 10 one-minute intervals of high-intensity work (i.e., > 90% HRmax) interspersed with nine one-minute intervals of self-paced active recovery (19-minutes total).
Study NCT02816567 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo - isotonic saline serum
Study NCT02816567 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sufentanil
Study NCT02816567 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sufentanil
Study NCT02816567 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: laparoscopic surgery
Study NCT05369247 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Continuous Training
Description: The MICT protocol consisted of 30-minutes of moderate intensity cycling (i.e., 64 - 76% HRmax).
Study NCT00620022 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol 300 μg
Description: Indacaterol was supplied in powder filled capsules together with a single dose dry powder inhaler (SDDPI) device.
Study NCT02816567 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: laparoscopic surgery
Study NCT00620022 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo was supplied in powder filled capsules together with a single dose dry powder inhaler (SDDPI) device.
Study NCT02457520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isotretinoin
Description: ABSORICA® (isotretinoin) capsules 0.5 mg/kg/day for 4 weeks followed by 1.0 mg/kg/day for 16 weeks
Study NCT00715702 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD5672
Description: 100 mg oral single dose
Study NCT00667862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Panobinostat
Study NCT00822497 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music-Based Imagery (MBI)
Description: MBI is form of music-assisted relaxation with imagery. This protocol is used at the patients' bedside before and after the debridement process.
Study NCT00822497 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Alternate Engagement (MAE)
Description: MAE consisted of a menu of music therapy interventions aimed at engaging the patients in music and diverting them away from the debridement process.
Study NCT00941837 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Olive Oil, Palm Olein Oil, Coconut Oil
Description: Effect of dietary fat type in combination with high protein on plasma homocysteine levels; 5 wk each with 2 wk wash out in between
Study NCT02202850 — intervention group
Intervention type: DRUG
Intervention: etanercept
Description: etanercept 1 x 50 mg/week or 2 x 25mg/week
Study NCT04832399 — intervention group
Intervention type: DRUG
Intervention: Natalizumab
Description: As described in the treatment arm.
Study NCT02841800 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 'Intra-luminal radiofrequency ablation (Habib EndoHPB)
Description: endobiliary radiofrequency ablation device
Study NCT01878825 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fluviral™
Description: 1 dose administered intramuscularly in deltoid region of non-dominant arm.
Study NCT01646788 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NMB Paclitaxel Drug Ejecting Balloon
Description: NMB's PTA Balloon catheter with drug
Study NCT01470482 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: No use of tourniquet
Description: Tourniquet is not applied i 25 pts
Study NCT01470482 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tourniquet
Description: Use of tourniquet
Study NCT04470180 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Teach to Goal
Description: Participants will complete inhaler education on a tablet device.
Study NCT04470180 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brief Instruction
Description: Participants will be read out loud instruction on how to use their inhaler.
Study NCT02183753 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: wood smoke
Study NCT02183753 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: clean air
Study NCT01287182 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ateronon
Description: Ateronon daily for 3 months
Study NCT04215757 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: peripheral nerve block
Description: peripheral nerve blocks with low dose lignocaine in acute radiculopathy
Study NCT04215757 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: peripheral nerve block
Description: peripheral nerve blocks with low dose lignocaine in acute radiculopathy
Study NCT05242796 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low frequency magnetic therapy
Study NCT05242796 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Low frequency magnetic therapy
Study NCT01495312 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SLT (selective laser trabeculoplasty ) SENSIMED Triggerfish
Description: SLT (single session; 180 to 360 degrees of angle will be treated)
Study NCT02931708 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diaphragm functional electrical stimulation
Description: Functional electrical stimulation: 80 Hz frequency, 0.4 ms pulse, rise 1s, 1s time on, decay 2s, 1s time off, intensity as patient tolerance
Study NCT00317278 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: massage therapy
Description: massage therapy to stable preterm infants
Study NCT00544934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLY-230
Description: 125, 250 0r 375 mg bid for 14 days
Study NCT00544934 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: No drug administered
Study NCT02544555 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intentional intraluminal approach
Description: Interventionist performs intentional intraluminal approach to angioplasty. Dedicated 018 and 014 guidewire for Chronic Total Occlusion (CTO) lesion and Chronic Total Occlusion (CTO) devices such as Truepath or Frontrunner can be chosen by interventionist. Methods to confirm successful intraluminal wiring will be selected, as follows; 1) examination for guidewire position in different two angles on fluoroscopy or 2) intravascular ultrasound (IVUS) exam after predilation is performed with an appropriately sized angioplasty balloon. After the guidewire is passed through the lumen of target lesion, predilation of the target lesion with an optimally sized balloon will be performed prior to stent implantation. Provisional stenting should be performed, if the case that optimal ballooning response is not obtained.
Study NCT02544555 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intentional subintimal approach
Description: Interventionist performs Intentional subintimal approach to angioplasty. 035 Terumo guidewires will be used. If 035 Terumo guidewire is not able to re-entry, Re-entry devices such as Offroad or OUTBACK catheter can be used. After the guidewire is passed through the subintimal layer of target lesion, predilation of the target lesion with an optimally sized balloon will be performed prior to stent implantation. Provisional stenting should be performed; the case that optimal ballooning response is not obtained should be enrolled. The sub-optimal balloon response is defined as a residual pressure gradient of >15 mmHg, residual stenosis of >30%, and flow-limiting dissection.
Study NCT00749333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD8566
Description: solution. Specific dose will be selected by the safety review committee
Study NCT00749333 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single 10ml oral solution.
Study NCT00923429 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stay-active care
Description: No other treatment than the stay-active care
Study NCT00923429 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stay-active care+stretching
Description: Stay-active care and muscle stretching at home and during physiotherapist appointments
Study NCT00923429 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stay-active+stretching+manual therapy
Description: Manual therapy in addition to stay-active care and stretching given during GP or physiotherapist appointments and matching home exercises
Study NCT00923429 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stay-active+stretching+manual therapy+steroid injections
Description: Manual therapy including steroid injection when indicated in addition to stay-active care and stretching during GP appointments (injections) and during GP or physiotherapist appointments (remaining treatment modalities)
Study NCT03275909 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated Psychological Therapy
Description: The psychological treatment includes 50 sessions of integrated psychological therapy focused on attentional skills, social perception skills, verbal communication skills, social skills and interpersonal problems solving skills and 10 sessions of specific emotional management therapy , designed for this research. and based on the contents developed by Hodel, Kern and Brenner
Study NCT01784835 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: osteopathic manipulative treatment
Description: Patients from this group received osteopathic treatments twice a week for the entire length of stay in the unit.
Study NCT01784835 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: Patients from control group received standard care plus osteopathic evaluation only, according to the same schedule as the study group.
Study NCT00317278 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Sham (placebo) provided to the control group
Study NCT01237522 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: A single dose study with one tablet of metformin 500 mg, time frame 24 hours
Study NCT03929822 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Contrast-Enhanced Spectral Mammography
Description: A standard dose of contrast material for other contrast mammography examinations and for body CT scanning, 1.5 ml/kg of Iohexol350 will be injected intravenously (IV) using a power injection (3-4 ml/s) with a maximum does of 150 ml. The IV injection is performed while the patient is in a sitting position. The mammogram will be performed in a standing position.
Study NCT01361048 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oral metronidazole
Description: 2 gm oral once
Study NCT01361048 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: neo penotran forte
Description: neo penotran forte intravaginal twice a day for 7 days
Study NCT01514162 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Trifecta valve
Description: surgical replacement of aortic valve
Study NCT01225666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MOD-4023
Description: liquid solution for subcutaneous injection - 30% of the cumulative weekly dose achieved with daily rhGH, Once weekly
Study NCT01225666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MOD-4023
Description: liquid solution for subcutaneous injection - 45% of the cumulative weekly dose achieved with daily rhGH, Once weekly
Study NCT01225666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MOD-4023
Description: liquid solution for subcutaneous injection - 100% of the cumulative weekly dose achieved with daily rhGH, Once weekly
Study NCT01361048 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: neo penotran forte once a day
Description: neo penotran forte intravaginally once a day for 7 days
Study NCT00538421 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Infusion intravenously (IV) 0-10 mg/kg/h
Study NCT00538421 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: 0,7-1,5 MAC
Study NCT03803800 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Classic, progressive endurance training
Description: Moderate intensity endurance training will be performed following a sequence of 5 training sessions every 2 weeks throughout the 12-week intervention. Sessions will include 60min of cycling on a stationary bicycle. Exercise intensity will match 60-80% of the maximal heart rate (HRmax)
Study NCT03803800 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Classic, progressive endurance training
Description: Moderate intensity endurance training will be performed following a sequence of 5 training sessions every 2 weeks throughout the 12-week intervention. Sessions will include 60min of cycling on a stationary bicycle. Exercise intensity will match 60-80% of the maximal heart rate (HRmax)
Study NCT03803800 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Periodized exercise training
Description: Throughout the 12-week periodized intervention, subjects will perform four recurrent 3-week cycles of moderate endurance training (week 1,three sessions, 60min/session, 60-80% HRmax), high intensity interval training (week 2, three sessions, 10min/session, 3x20sec supramaximal sprint interspersed with recovery intervals of 2min), and recovery weeks (week 3, one high intense interval session as described above)
Study NCT03803800 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Periodized exercise training
Description: Throughout the 12-week periodized intervention, subjects will perform four recurrent 3-week cycles of moderate endurance training (week 1,three sessions, 60min/session, 60-80% HRmax), high intensity interval training (week 2, three sessions, 10min/session, 3x20sec supramaximal sprint interspersed with recovery intervals of 2min), and recovery weeks (week 3, one high intense interval session as described above)
Study NCT03803800 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: beta-alanine
Description: Some subjects will receive the ergogenic supplement beta-alanine.
Study NCT03503422 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Real transcranial direct current stimulation + therapeutic exercises for back pain
Description: Real transcranial direct current stimulation associated with therapeutic exercises for back pain~tDCS: 20 minutes, 2mA, primary motor cortex anode (contralateral to the lesion) and supraorbital cathode (ipsilateral to the lesion).Technique based on the application of weak, direct electrical current to the brain through relatively large electrodes that are placed over the scalp, in which anodal and cathodal stimulation increases and decreases cortical excitability, respectively.
Study NCT03503422 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham transcranial direct current stimulation + therapeutic exercises for back pain
Description: Sham transcranial direct current stimulation associated with therapeutic exercises for back pain.~tDCS: 20 minutes (30 seconds ON), 2mA, primary motor cortex anode (contralateral to the lesion) and supraorbital cathode (ipsilateral to the lesion). Technique based on the application of weak, direct electrical current to the brain through relatively large electrodes that are placed over the scalp, in which anodal and cathodal stimulation increases and decreases cortical excitability, respectively
Study NCT00885456 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PREVENT program
Description: 12-week program of aerobic/strengthening exercises and education designed to induce physiological and behavioral changes deemed necessary to reduce vascular risk
Study NCT00885456 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Three or more out-patient visits to the neurovascular clinic for assessment, counseling and referral to appropriate health care professionals.
Study NCT01225666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MOD-4023
Description: liquid solution for subcutaneous injection - 100% of the cumulative weekly dose achieved with daily rhGH, every-other week (50% of the two-weekly cumulative dose)
Study NCT01089660 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Swine A/H1N1 influenza vaccine (split virion, inactivated)
Description: 0.3 mL, Intramuscular (IM)
Study NCT02012153 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal Stromal Cells
Study NCT00720265 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prograf
Description: oral
Study NCT00720265 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MR4
Description: oral
Study NCT03699020 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Description: Empirically based behavioral intervention that encourages acceptance of circumstances with commitment and behavioral change strategies to improve psychological flexibility.
Study NCT03699020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chronic Pain Education
Description: Education materials about living with chronic pain developed by Weill Cornell Universitys Translational Research Institute for Pain in Later Life
Study NCT01988909 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WR 279,396
Description: Paromomycin + Gentamicin Topical Cream
Study NCT05956366 — intervention group
Intervention type: BEHAVIORAL
Intervention: Family-based treatment
Description: Open-end family therapy ad modum The Maudsley model
Study NCT04385771 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: vv-ECMO + cytokine adsorption (Cytosorb adsorber)
Description: in COVID-19-diseased vv-ECMO patients additional treatment with cytokine adsorption using a Cytosorb adsorber will be randomized (vs. control group)
Study NCT04385771 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: vv-ECMO only (no cytokine adsorption)
Description: COVID-19-diseased treated with vv-ECMO
Study NCT01089660 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Swine A/H1N1 influenza vaccine (split virion, inactivated)
Description: 0.5 mL, Intramuscular (IM)
Study NCT02601794 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App-based Mindfulness Training
Description: A commercially available mindfulness training app delivered to smartphone or tablet.
Study NCT03677622 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Voluven to near maximal stroke volume of the heart
Description: Stroke volume guided fluid treatment with Voluven on the basis of restricted fluid therapy
Study NCT03677622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Voluven to near maximal stroke volume of the heart
Description: Stroke volume guided fluid treatment with Voluven on the basis of restricted fluid therapy
Study NCT02495545 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: CSFD and elevation of MAP
Description: Lumbar drain placement with CSFD with elevation of MAP
Study NCT02495545 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Maintenance of MAP
Description: Lumbar drain placement without CSFD and with maintenance of MAP
Study NCT00940810 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Plasma Disc Decompression/Nucleoplasty
Description: Subjects assigned to the PDD Group will be scheduled to receive the plasma disc decompression procedure using the Coblation® method.~Similarly to in Conservative Care group, subjects will be followed-up at 2, 8 weeks, 6 and 12 months (calculated from the date of the PDD procedure). The follow-up visits will consist of a brief physical examination in the clinic and completion of study questionnaires.
Study NCT00940810 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conservative Care (physiotherapy)
Description: Subjects assigned to the Conservative Care Group will be scheduled to receive physical therapy according to standard and customary care locally.~Subjects will be followed-up at 2, 8 weeks, 6 and 12 months . (Calculated from the time of first going through the individual training programme).The follow-up visits will consist of a brief physical examination in the clinic and completion of study questionnaires.
Study NCT00496548 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fecal calprotectin
Description: Fecal calprotectin levels obtained and compared to urinary PGE-M and serum C-reactive protein (CRP) levels.
Study NCT00496548 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Urinary PGE-M Level
Description: Urinary PGE-M level obtained and compared to fecal calprotectin and serum CRP levels.
Study NCT01513486 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: immobilization